drug · antibody
patient view →mirikizumab
Marketedupdated 2mo agoby Eli Lilly and Co🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 3 investigational indications.
indications
investigational
IBD (Crohn's + UC)
targets
Interleukin-23
all catalysts(5)
approval · 5
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that